Stock Ratings | Citigroup maintained its "buy" rating on Shattuck Labs (STTK) and raised its price target to $18, implying a potential upside of 321.55%; Maxim Group raised its price target for Apple (AAPL) to $350.

Shattuck Labs, Inc.
Gloo Holdings, Inc. Class A
Applied Digital
Kyntra Bio, Inc.
Bragg Gaming Group Inc.

Shattuck Labs, Inc.

STTK

0.00

Gloo Holdings, Inc. Class A

GLOO

0.00

Applied Digital

APLD

0.00

Kyntra Bio, Inc.

KYNB

0.00

Bragg Gaming Group Inc.

BRAG

0.00

The ratings of major US investment banks are used to track the latest valuations and target prices on Wall Street daily, and to explore potential equity investment opportunities.

Risk warning:

Investing in small-cap stocks can be risky. Be prepared for potential challenges related to liquidity, high volatility, limited information, and financial instability. Always diversify your investments.

Today's key assessments and concerns

Citigroup: Maintaining its "Buy" rating on Shattuck Labs ( Shattuck Labs, Inc.(STTK.US) ), while raising its price target from $7 to $18.

Benchmark: Maintaining a "buy" rating on Gloo Holdings ( Gloo Holdings, Inc. Class A(GLOO.US) ), with a price target raised from $14 to $15.

Lake Street: Maintaining a "buy" rating on Applied Digital ( Applied Digital(APLD.US) ), while raising the price target from $70 to $90.

Rodman & Renshaw: Initial rating for Kyntra Bio ( Kyntra Bio, Inc.(KYNB.US) ) at "Buy", with a target price of $30.

Maxim Group maintains its "buy" rating on Bragg Gaming Group ( Bragg Gaming Group Inc.(BRAG.US) ), while lowering its price target from $8 to $6.

The symbol Classification Target price Current price Percentage of potential increase/decrease (Classification) Agency
Shattuck Labs, Inc.(STTK.US) to lift $18.0 $4.27 321.55% Citigroup
Gloo Holdings, Inc. Class A(GLOO.US) to lift $15.0 $4.78 213.81% Benchmark
Applied Digital(APLD.US) to lift $90.0 $41.91 114.75% Lake Street
Zevra Therapeutics, Inc.(ZVRA.US) to lift $29.0 $13.66 112.3% Canaccord Genuity
Tango Therapeutics, Inc.(TNGX.US) to lift $66.0 $31.56 109.13% HC Wainwright & Co.
Kyntra Bio, Inc.(KYNB.US) Initial classification $30.0 $6.69 348.43% Rodman & Renshaw
Bragg Gaming Group Inc.(BRAG.US) cut $6.0 $1.69 255.03% Maxim Group
Wix.com Ltd.(WIX.US) cut $135.0 $48.22 179.97% B. Riley Securities
GOOSEHEAD INSURANCE, INC.(GSHD.US) cut $67.0 $35.92 86.53% UBS
Baldwin Insurance Group, Inc. Class A(BWIN.US) cut $35.0 $19.36 80.79% UBS

comments:
Target price unit and current price: US Dollar;
Current price: As of the latest closing price of US stocks;
Potential percentage increase/potential decrease = (Agency target price - current price) / current price 100% (Current price = Last closing price up to the time of the count)

Lifting

Morgan Stanley: Maintaining Apple's Apple Inc.(AAPL.US) rating at "overweight", while raising the price target from $330 to $360.

TD Securities: Maintaining a "buy" rating on Google-C ( Alphabet Inc. Class C(GOOG.US) ) stock, while raising the price target from $450 to $475.

UBS: Maintaining a "neutral" rating on Jabil ( Jabil Inc.(JBL.US) ), while raising its price target from $273 to $380.

B of A Securities: Maintain Oracle's Oracle Corporation(ORCL.US) rating at "Buy", while raising the target price from $200 to $240.

Wells Fargo: Maintaining Texas Instruments Texas Instruments Incorporated(TXN.US) ) rating at "Market Weight", while raising price target from $260 to $300.

First Coverage

Canaccord Genuity: Initial rating for Barrick Gold ( Barrick Gold Corp.(GOLD.US) ) at "Buy", with a target price of $70.

Benchmark: Preliminary rating for International Flavors & Fragrances Inc.(IFF.US) ) stock at "buy", with a target price of $100.

Citizens: Parker-Hannifin ( Park Aerospace Corp.(PKE.US) ) initial rating at "outperforms the market", with a price target of $42.

reduction

Keefe, Bruyette & Woods: Downgraded Lennar Lennar Corporation Class A(LEN.US) ) stock to "underperforming," with a price target cut from $97 to $86.

Truist Securities: Maintaining a "buy" rating on Vail Resorts ( Vail Resorts, Inc.(MTN.US) ), while lowering its price target from $212 to $195
Wells Fargo: Downgraded Nuvalent ( Nuvalent, Inc. Class A(NUVL.US) ) stock to "Market-equal weight," while raising its price target from $116 to $124.

Editor's Note: This content was created by Saham's AI-powered SaaS tool and reviewed by our editorial team.
Risk warning:
Investing involves risk, and securities prices can rise or fall, or even become worthless. Investing does not guarantee profits and may result in losses. Past performance is not necessarily indicative of future results. Before making any investment decision, investors should assess their financial situation, investment objectives, experience, and risk tolerance, and understand the nature of the investment products and their associated risks. For more details on the nature and risks of each investment product, please read the relevant offering documents carefully. If you have any questions, it is advisable to seek independent professional advice.